RxDoctor Payments Data

William Lucas, MD

Family Medicine · Dallas, ORNPI 1326026261

Payments from drug & device makers

$2,143in general payments, 2019–2025

Across 92 payments — averaging $23.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$269
  • E.r. Squibb & Sons, L.L.C.$242
  • Amgen$201
  • Lilly USA, LLC$169
  • Bayer$167
  • Abbott$166
  • plus $930 from 16 others

What the payments were for

  • Food & beverage$2,08997%
  • Education$553%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,143 in reported general payments places this provider in the 90th percentile of 1,221 family medicine providers in Oregon.

See all family medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$64,054
Medicare patients
151
Services billed
670

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban106$113,087
JardianceEmpagliflozin44$69,572
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog27$58,025
ProliaDenosumab20$33,207
Humalog Kwikpen U-200Insulin Lispro22$32,689
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog39$26,031
FarxigaDapagliflozin Propanediol17$16,473
Combivent RespimatIpratropium/Albuterol Sulfate26$16,292
Semglee (Yfgn) PenInsulin Glargine-Yfgn23$15,668
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$15,039
Atorvastatin Calcium749$10,924
Lantus SolostarInsulin Glargine,hum.Rec.Anlog65$10,469
Spiriva RespimatTiotropium Bromide16$9,151
Fluticasone-SalmeterolFluticasone Propion/Salmeterol55$7,262
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen228$6,560

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$269$113,087106 claims
Boehringer IngelheimJardiance, Combivent Respimat, Spiriva Respimat$41$95,01586 claims
AmgenProlia$201$33,20720 claims
AstraZenecaFarxiga$19$16,47317 claims
GSKTrelegy Ellipta$119$15,03916 claims
AbbVieCreon$23$5,22912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,221 family medicine providers in Oregon.

Other family medicine in Dallas

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →